Pharmacokinetics of 3 Formulations of Ibuprofen Suppositories
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetic and bioavailability
characteristics of two test formulations of ibuprofen for rectal administration with the
profile of a marketed reference formulation of ibuprofen 200 mg (for oral administration).
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide